PREMIER Biosoft and JEOL enter into an agreement to advance research in MALDI Imaging
PREMIER Biosoft and JEOL today announced that they have signed a co-marketing agreement for MALDIVision, a MALDI Imaging Mass Spectrometry (MALDI IMS) data analysis tool which aims to provide a comprehensive tool for advancing research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology.
- San Francisco, CA (1888PressRelease) June 04, 2013 - PREMIER Biosoft and JEOL today announced that they have signed a co-marketing agreement for MALDIVision, a MALDI Imaging Mass Spectrometry (MALDI IMS) data analysis tool. The collaboration aims to provide a comprehensive tool for advancing research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology. Under this agreement, JEOL will promote MALDIVision along with its JMS-S3000 SpiralTOF™ Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometer.
MALDIVision visualizes and analyzes spatial distribution of analytes in a sampled tissue section. MALDIVision is the only tool on the market to seamlessly load and analyze imaging data files up to 20 GB. The program generates high quality reconstituted MALDI images in 2D and 3D based on the m/z value of target compounds. Users can overlay up to 10 MALDI images for visualization of spatial distribution of different compounds present in a sample.
According to Yoshihisa Ueda, the general manager of the Mass Spectrometry Business Unit JEOL Ltd., "Our JMS-S3000 SpiralTOF™ has the highest mass resolving power among any MALDI-TOFMS on the market. This imposes a unique challenge to the imaging data analysis software; the amount of information and, thus, the size of the imaging data from SpiralTOF is also the largest. After rigorous evaluation, we found that MALDIVision can process such data flawlessly. We are quite excited that, by combining SpiralTOF and MALDIVision, now we can offer a powerful and unique solution for the cutting edge research in life science and material science."
"Mass Spectrometry is a rapidly growing platform for biomarker discovery. This collaboration will provide the research community, especially in the Asia-Pacific region, with a powerful tool to support mass spectrometry based imaging applications," said Arun Apte, CEO at PREMIER Biosoft,
For details, please visit: http://www.premierbiosoft.com/maldi-tissue-imaging/index.html
About PREMIER Biosoft
Founded in 1994, PREMIER Biosoft is led by computer scientists and biologists dedicated to producing cutting edge intuitive software for research in life sciences. The company's goal is to study the most recent innovations in life sciences and translate them into software products to aid research. For more information about the company, go to www.premierbiosoft.com.
Follow PREMIER Biosoft on Twitter ( @ ) PREMIERBiosoft and on Facebook
http://www.facebook.com/pages/PREMIER-Biosoft-International/259990866444.
Contact:
Shonali Paul
PREMIER Biosoft
650-856-2703
http://www.premierbiosoft.com
Email: support ( @ ) premierbiosoft dot com
Yoshihisa Ueda
General Manager, MS Business Unit
JEOL Ltd.
Request Product INFO
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam